WEBINAR: November the 14th 2024 – Worldwide Clinical Experience of Sudoscan in the Managment and Prevention of Diabetes Complications – Read more about our Webinar !
SUDOSCAN efficacy in early detection of diabetic neuropathy has been demonstrated in several studies.
Small fiber neuropathies have been assessed using SUDOSCAN in different diseases and therapeutic areas.
SUDOSCAN has demonstrated its clinical utility to detect chemotherapy induced polyneuropathy (CIPN).
SUDOSCAN has demonstrated its clinical utility in Nephrology.
A key clinical application of SUDOSCAN is longitudinal follow-up and patient management.